Back to Search
Start Over
PD46-12 PRECLINICAL STUDIES USING CISPLATIN/CARBOPLATIN TO RESTORE THE ENZALUTAMIDE SENSITIVITY VIA DEGRADING THE ANDROGEN RECEPTOR SPLICING VARIANT 7 (ARV7) TO FURTHER SUPPRESS ENZALUTAMIDE RESISTANT PROSTATE CANCER
- Source :
- Journal of Urology. 207
- Publication Year :
- 2022
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2022.
- Subjects :
- Urology
Subjects
Details
- ISSN :
- 15273792 and 00225347
- Volume :
- 207
- Database :
- OpenAIRE
- Journal :
- Journal of Urology
- Accession number :
- edsair.doi...........1d1ca7886721d1212e4a6c6897fe5167
- Full Text :
- https://doi.org/10.1097/ju.0000000000002614.12